Ketamine and TMS are being used at present to successfully treat patients with intractable depression.
Two doses of the “magic mushroom” chemical psilocybin relieve symptoms for people with major depression for at least a month.
Half of the study participants no longer considered themselves to be in throes of major depression one month after psychedelic psilocybin treatment.
At present, Psilocybin is a Schedule 1 drug and is only available through an authorized clinical trial.